J. Ferlay, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer, vol.136, pp.359-386, 2015.
DOI : 10.1002/ijc.29210

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.29210

A. Carrato, A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs, J. Gastrointest. Cancer, vol.46, pp.201-211, 2015.

D. S. Jones, S. H. Podolsky, and J. A. Greene, The burden of disease and the changing task of medicine, N. Engl. J. Med, vol.366, pp.2333-2338, 2012.

H. Brenner, Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis, Lancet, vol.360, pp.1131-1135, 2002.

E. Azoulay, Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium-a groupe de recherche respiratoire en réanimation onco-hématologique study, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.31, pp.2810-2818, 2013.

, Survival in neutropenic patients with severe sepsis or septic shock, p.31, 2018.

E. Azoulay, Intensive care of the cancer patient: recent achievements and remaining challenges, Ann. Intensive Care, vol.1, p.5, 2011.

F. Pène, Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit*, Crit. Care Med, vol.36, p.690, 2008.

V. Koppurapu, K. Chatterjee, A. Goyal, and C. Punjabi, 584: Biliary Drainage Method Preference And National Utilization In Septic Shock Due To Cholangitis, Crit. Care Med, vol.44, 2016.

C. J. Karvellas, The impact of delayed biliary decompression and anti-microbial therapy in 260 patients with cholangitis-associated septic shock, Aliment. Pharmacol. Ther, vol.44, pp.755-766, 2016.

D. W. Lee, Biliary decompression by nasobiliary catheter or biliary stent in acute suppurative cholangitis: a prospective randomized trial, Gastrointest. Endosc, vol.56, pp.361-365, 2002.

A. C. Moss, E. Morris, J. Leyden, and P. Macmathuna, Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results, Cancer Treat. Rev, vol.33, pp.213-221, 2007.

A. C. Moss, E. Morris, J. Leyden, and P. Macmathuna, Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction, Eur. J. Gastroenterol. Hepatol, vol.19, pp.1119-1124, 2007.

E. L. Artifon, Surgery or endoscopy for palliation of biliary obstruction due to metastatic pancreatic cancer, Am. J. Gastroenterol, vol.101, pp.2031-2037, 2006.

A. C. Moss, E. Morris, J. Leyden, and P. Macmathuna, Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results, Cancer Treat. Rev, vol.33, pp.213-221, 2007.
DOI : 10.1016/j.ctrv.2006.10.006

B. C. Sharma, R. Kumar, N. Agarwal, and S. K. Sarin, Endoscopic biliary drainage by nasobiliary drain or by stent placement in patients with acute cholangitis, Endoscopy, vol.37, pp.439-443, 2005.

, Prothèses biliaires et obstructions malignes des voies biliaires extrahépatiques

J. , Oncologie Digestive-Traitement palliatif endoscopique des obstructions malignes des voies biliaires, p.24, 2018.

J. H. Lee, T. Davee, and . Biliary, Obstruction: Endoscopic Approaches. Semin. Interv. Radiol, vol.34, pp.369-375, 2017.

M. Singer, The Third International Consensus Definitions for Sepsis and Septic Shock

, JAMA, vol.315, pp.801-810, 2016.

A. Rhodes, Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock, Crit. Care Med, vol.45, pp.486-552, 2016.

, Insuffisance rénale aiguë en périopératoire et en réanimation (A l'exclusion des techniques d'épuration extrarénale), p.24, 2015.

A. Venara, L'iléus postopératoire. Mécanismes, incidence, prévention, 2016.

E. Kostakou, N. Rovina, M. Kyriakopoulou, N. G. Koulouris, and A. Koutsoukou, Critically ill cancer patient in intensive care unit: issues that arise, J. Crit. Care, vol.29, pp.817-822, 2014.

P. B. Massion, Prognosis of hematologic malignancies does not predict intensive care unit mortality, Crit. Care Med, vol.30, pp.2260-2270, 2002.

E. Azoulay and B. Afessa, The intensive care support of patients with malignancy: do everything that can be done, Intensive Care Med, vol.32, pp.3-5, 2006.

D. D. Benoit, Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies, Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Ren. Assoc, vol.20, pp.552-558, 2005.

E. Maccariello, Outcomes of cancer and non-cancer patients with acute kidney injury and need of renal replacement therapy admitted to general intensive care units, Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Ren. Assoc, vol.26, pp.537-543, 2011.

P. M. Honore, R. Jacobs, E. De-waele, M. Diltoer, and H. D. Spapen, Renal blood flow and acute kidney injury in septic shock: an arduous conflict that smolders intrarenally?, Kidney Int, vol.90, pp.22-24, 2016.

R. P. Burden, D. V. Ash, W. N. Boyd, J. G. Gray, and G. M. Aber, Acute reversible renal failure in patients with acute cholecystitis and cholangitis, Q. J. Med, vol.44, pp.65-77, 1975.

A. Boon, A. C. Bulmer, J. S. Coombes, and R. G. Fassett, Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations, Am. J. Physiol. Renal Physiol, vol.307, pp.123-136, 2014.

, Elevated bilirubin levels are associated with a better renal prognosis and ameliorate kidney fibrosis, p.8, 2018.

S. W. Oh, Bilirubin attenuates the renal tubular injury by inhibition of oxidative stress and apoptosis, BMC Nephrol, vol.14, p.105, 2013.

A. Boyer, Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk, Drug Saf, vol.36, pp.217-230, 2013.

P. Malacarne, S. Bergamasco, and C. Donadio, Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients, Chemotherapy, vol.52, pp.178-184, 2006.

M. Paul, I. Benuri-silbiger, K. Soares-weiser, and L. Leibovici, Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and metaanalysis of randomised trials, BMJ, vol.328, p.668, 2004.

W. Picard, Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock, Antimicrob. Agents Chemother, vol.58, pp.7468-7474, 2014.

F. Goutorbe, Temporary placement of a covered duodenal stent can avoid riskier anterograde biliary drainage when ERCP for obstructive jaundice fails due to duodenal invasion, Surg. Endosc, vol.31, pp.625-631, 2017.

M. J. Schwaber and Y. Carmeli, Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis, J. Antimicrob. Chemother, vol.60, pp.913-920, 2007.

D. Marchaim, National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases, Antimicrob. Agents Chemother, vol.54, pp.5099-5104, 2010.

E. M. Trecarichi, R. Cauda, and M. Tumbarello, Detecting risk and predicting patient mortality in patients with extended-spectrum ?-lactamase-producing Enterobacteriaceae bloodstream infections, Future Microbiol, vol.7, pp.1173-1189, 2012.

J. Rodríguez-baño, E. Picón, and P. Gijón, Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli, J. Clin. Microbiol, vol.48, issue.5, pp.1726-1731, 2010.

O. F. Quirante, S. G. Cerrato, and S. L. Pardos, Risk factors for bloodstream infections caused by extendedspectrum ?-lactamase-producing Escherichia coli and Klebsiella pneumoniae, Braz. J. Infect. Dis. Off. Publ. Braz. Soc. Infect. Dis, vol.15, pp.370-376, 2011.

, Exhaustive review on the clinical and economic impact of infections caused by common multidrugresistant Gram-negative bacilli, including ESBL producers.Giske CG, Monnet DL, Cars O, Carmeli Y; ReActAction on Antibiotic Resistance. Clinical and economic impact of common multidrug-resistant Gram-negative bacilli, Antimicrob. Agents Chemother, vol.52, issue.3, pp.813-821, 2008.

O. F. Quirante, S. G. Cerrato, S. Pardos, M. Tumbarello, T. Spanu et al., Crossref, CAS. 47. Comprehensive review of the epidemiology, clinical aspects and treatment options of infections caused by extended-spectrum-?-lactamase (ESBL)-producing Enterobacteriaceae.Rodríguez-Baño J, Pascual A. Clinical significance of extended-spectrum beta-lactamases, Expert Rev. Anti Infect. Ther, vol.15, issue.4, pp.671-683, 2008.

M. J. Schwaber, Clinical and economic impact of bacteremia with extended-spectrum-betalactamase-producing Enterobacteriaceae, Antimicrob. Agents Chemother, vol.50, pp.1257-1262, 2006.

C. Kang, Risk factors for infection and treatment outcome of extended-spectrum ?-lactamaseproducing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy, Ann. Hematol, vol.91, pp.115-121, 2012.

E. M. Trecarichi, Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies, J. Infect, vol.58, pp.299-307, 2009.

M. Alevizakos, Bloodstream infections due to extended-spectrum ?-lactamase-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis, Int. J. Antimicrob. Agents, vol.50, pp.657-663, 2017.

M. Alevizakos, S. Karanika, M. Detsis, and E. Mylonakis, Colonisation with extended-spectrum ?lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis, Int. J. Antimicrob. Agents, vol.48, pp.647-654, 2016.

M. Tumbarello, Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome, Antimicrob. Agents Chemother, vol.50, pp.498-504, 2006.

, Accessed: 25th February 2018) 55. van der Gaag, N. A. et al. Preoperative biliary drainage for cancer of the head of the pancreas, Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a ...-PubMed-NCBI. Available at, vol.362, pp.129-137, 2010.

H. Kawashima, Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications, Ann. Surg, vol.257, pp.121-127, 2013.

Y. Shaib, M. A. Rahal, M. O. Rammal, A. Mailhac, and H. Tamim, Preoperative biliary drainage for malignant biliary obstruction: results from a national database, J. Hepato#biliary#pancreatic Sci, vol.24, pp.637-642, 2017.

M. E. Sewnath, T. M. Karsten, M. H. Prins, E. Rauws, H. Obertop et al., A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice, Ann Surg, vol.236, pp.17-27, 2002.

I. Sourrouille, Five days of postoperative antimicrobial therapy decreases infectious complications following pancreaticoduodenectomy in patients at risk for bile contamination, HPB, vol.15, pp.473-480, 2013.

F. Gavazzi, Role of preoperative biliary stents, bile contamination and antibiotic prophylaxis in surgical site infections after pancreaticoduodenectomy, BMC Gastroenterol, vol.16, p.43, 2016.

J. Dumonceau, Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline, Endoscopy, vol.44, pp.277-298, 2012.